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Hypopigmented mycosis fungoides (HMF) is a clinical variant of MF presenting a good prognosis. In this
report, we describe a case of HMF with dense inﬁltration of tumor-inﬁltrating leukocytes that bear
several cytotoxic molecules, such as granulysin and T-cell intracellular antigen-1. In addition, our
immunohistochemical study revealed that the ratio of Foxp3þ regulatory T cells to the total CD4þ cells is
decreased in the lesional skin of HMF, compared with that of conventional MF. Our case suggested
possible mechanisms for the hypopigmentation and good prognosis of this type of MF.
Copyright © 2015, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Hypopigmented mycosis fungoides (HMF) is described as a clinical
variant of MF presenting a good prognosis,1,2 but the condition is
not clearly deﬁned by the World Health Organization or the Euro-
pean Organization for Research and Treatment of Cancer classiﬁ-
cation of cutaneous lymphoma.3 Recently, Boulos et al reported a
case series of 34 patients with juvenile-onset mycosis fungoides,1
which suggested that 53% of juvenile-onset MF is a hypo-
pigmented type, and about 40% of them contained CD8þ immu-
nophenotypes.1 Notably, the inﬁltration of CD8 determines the
prognosis of several types of lymphomas, which suggested possible
reasons for the good prognosis of HMF.4,5
Regulatory T cells (Tregs) are classically identiﬁed by the
expression of CD4, CD25, and Foxp3.6 Tregs induce immunological
tolerance in cancer patients by a variety of mechanisms together
with other suppressor cells.7 For instance, depletion of CD4þCD25þ
Tregs enhances the immune responses against tumor antigens to
induce an antitumor immune response in melanoma patients.8 In
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al Association. Published by Elsevidifference in Tregs between invasive and noninvasive skin tumors,
such as extramammary Paget's disease (EMPD), squamous-cell
carcinoma, and Bowen disease.9e11 These reports suggested that
the ratio of Tregs could be connectedwith the cancer progression in
skin tumors. In this report, we describe a case of HMF, and inves-
tigate the proﬁles of tumor-inﬁltrating leukocytes (TILs) in the
lesional skin of this patient.Case Report
A 22-year-old Japanesewoman visited our outpatient clinic with an
11-year history of multiple vitiligo. She had been treated with
topical 0.1% tacrolimus for 9 years for vitiligo vulgaris in another
clinic. On her initial visit, physical examination revealed multiple
vitiligo with central faint erythema on the lateral side of her trunk
and lower limbs (Figure 1A). A biopsy specimen showed that
atypical large lymphocytes densely inﬁltrated mainly the upper
dermis region with involvement of the overlying epidermis
(Figure 1B). Immunohistochemical staining revealed that these
atypical lymphocytes, which were distributed from the upper layer
of stratum spinosum to the dermis, were negative for CD4
(Figure 1C) and CD7 (Figure 1D), and positive for CD3, CD5, and CD8
(Figure 1E). There were few CD161þ cells in the dermis. To further
conﬁrm the proﬁles of TILs in MF, we employed double staining for
CD8 with granulysin (Figure 2A) or CD8 with CD7 (Figure 2B),
which revealed that CD8þgranulysinþ cells and CD8þCD7þ cells
were distributed at the basal layers of the epidermis and theer Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Figure 1 (A) Multiple vitiligo with central faint erythema on the lower limbs. (B) Atypical large lymphocytes can be seen densely inﬁltrating mainly the upper dermis with
involvement of the overlying epidermis. Parafﬁn-embedded tissue samples were deparafﬁnized and stained with (C) anti-CD4Ab, (D) anti-CD7Ab, or (E) anti-CD8Ab. The sections
were developed with 3,30-diaminobenzidine tetrahydrochloride (C) (original magniﬁcation 200). Ab ¼ antibody.
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distributed from the upper layer of stratum spinosum to the
dermis. Substantial numbers of T-cell intracellular antigen-1 (TIA-
1)þ cells were also detected in the area of distribution of TILs (data
not shown). The double staining of Foxp3 with CD4, CD8, or CD25
revealed that substantial numbers of CD4þFoxp3þ cells and
CD25þFoxp3þ cells were detected in the dermis (Figure 2C). There
is no CD8þFoxp3þ cell in the lesional skin of HMF, as we previously
reported (data not shown).10 The percentage of Foxp3þ cells was
18.4% ± 6.7% and 16.7% ± 6.3% among CD4þ cells and CD25 cells,
respectively. We summarized the ratio of Foxp3þ cells in our case
and compared it with the ﬁve cases of conventional MF, ﬁve cases of
noninvasive EMPD, and invasive EMPD cases, as we previously re-
ported (Figure S1).10,12 We treated our patient with narrow-band
UVB ﬁve times a week for 4 weeks; most lesions, however, repig-
mented 2 months after the treatment.
Discussion
HMF is described as a juvenile type of MF that has a relatively good
prognosis compared with conventional MF.1,2 Although the prog-
nosis of HMF is relatively good, and the proﬁles of TILs determinethe prognosis of cutaneous T-cell lymphoma (CTCL),4,5,13 the pre-
cise immunological proﬁles of HMF have not been reported yet.
Therefore, in this report, we shed light on the proﬁles of T cells
inﬁltrating around the tumor cells, particularly focusing on Tregs
and cytotoxic molecules.
To investigate the Tregs in HMF, we employed double staining
for CD4/Foxp3 and CD25/Foxp3, which revealed a decrease in the
ratio of Foxp3þ on CD4 cells and CD25þ cells in the lesional dermis
of HMF compared with conventional MF. As we previously re-
ported, the ratio of Foxp3þ Tregs in MF is approximately 30% in the
dermis, which is much higher than in skin inﬂammatory disorders,
such as psoriasis (5%) and eczematous dermatitis (15%).12
Compared with conventional MF, the ratio of Foxp3þ Tregs in our
case was decreased. Notably, a recent report suggested that Tregs
play a pivotal role in maintaining peripheral tolerance that actively
suppresses effector T cells.7 In the tumor site, in concert with
tumor-associated macrophages, Tregs maintain the immunosup-
pressive microenvironment and promote tumor growth.7 For
example, Mahnke et al8 reported that the depletion of Tregs in
melanoma patients in vivo resulted in enhanced immune functions
and the substantial development of antigen-speciﬁc CD8þ T cells in
vaccinated individuals. Ni et al5 reported that the reduction of Tregs
Figure 2 Parafﬁn-embedded tissue samples were deparafﬁnized and double stained
with (A) anti-CD8Ab (brown) with antigranulysin Ab (red), (B) anti-CD8Ab (brown)
with anti-CD7Ab (red), or (C) anti-CD25Ab (brown) with anti-Foxp3Ab (red). The
sections were developed with liquid permanent red and 3,30-diaminobenzidine
tetrahydrochloride (original magniﬁcation: 200). Ab ¼ antibody.
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proves the prognosis in patients with CTCL. These reports sug-
gested that the reduction of Tregs contributes to the increase in the
number of CD8þ cells and natural killer cells in patients with MF,5
which might determine the therapeutic effects of mogamulizu-
mab for MF. Indeed, in contrast to the decrease of Foxp3þ Tregs inour case, substantial numbers of CD7þCD8þgranulysinþ cells were
detected.
Among the cytotoxic molecules, we investigated granulysin and
TIA-1 in this case. Recently, the expression of granulysin has been
reported to determine the prognosis of several types of lym-
phomas.4,13,14 Another cytotoxic molecule, TIA-1 in the TILs, is also
reported to correlate with the therapeutic effect of several reagents
for various types of cancer, including lymphomas.15 These reports
supported the hypothesis that a better prognosis of HMF might be
due to the cytotoxic molecules-bearing cells.
In this report, we presented a case of HMF with dense inﬁltra-
tion of TILs that bear several cytotoxic molecules. In addition, our
immunohistochemical study revealed that the ratio of Foxp3þ Tregs
is decreased in the lesional skin of HMF compared with that of
conventional MF. Our case suggested possible mechanisms for the
hypopigmentation and good prognosis of this type of MF.
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